171 completed, 39 unknown, 16 recruiting, 15 terminated. 80 Phase 1, 46 Phase 4, 32 Phase 3, 24 Phase 2, 16 Not applicable.
Follow Dabigatran: new trials by email Literature Review of Dabigatran trials Research Report on Dabigatran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs and Processes Two Commonly Used Medicines: Dabigatran, a Blood Thinner, and Rosuvastatin, a Medicine Used to Lower Cholesterol Dabigatran Etexilate, Rosuvastatin, CHF10196 - Healthy Male Volunteers | Phase 1 | Not yet recruiting | Chiesi Farmaceutici S.p.A. | 24 | 2026-10-27 | 2026-08-04 |
| A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395 BGB-43395, Midazolam, Celecoxib - Healthy Adult Participants | Phase 1 | Recruiting | BeOne Medicines | 24 | 2026-09-25 | 2026-10-23 |
| Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants Vimseltinib, Dabigatran - Healthy Male Participants | Phase 1 | Recruiting | Deciphera Pharmaceuticals, LLC | 20 | 2026-09-01 | 2026-09-25 |
| Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy Rivaroxaban, or Edoxaban , or Apixaban , or Dabigatran, Aspirin - Stroke, Acute Ischemic Stroke | Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 680 | 2026-08-15 | 2026-08-05 |
| Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants BMS-986533, Famotidine, Placebo - Healthy Volunteers | Phase 1 | Recruiting | Bristol-Myers Squibb | 136 | 2026-07-13 | 2026-07-24 |
| STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism Anticoagulants, Thrombolytic Agents, Mechanical Thrombectomy Devices - Pulmonary Embolism, Venous Thromboembolism | Not yet recruiting | Nanjing First Hospital, Nanjing Medical University | 1300 | 2026-06-01 | 2026-05-22 | |
| A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults Nurandociguat, Rosuvastatin, Dabigatran etexilate - Chronic Kidney Disease | Phase 1 | Withdrawn | Bayer | 2026-04-08 | 2026-05-12 | |
| Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia Dabigatran, Apixaban, edoxaban - Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia | Phase 4 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 300 | 2026-01-15 | 2026-09-24 |
| A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants PF-08049820, Midazolam, Dabigatran Etexilate - Atopic Dermatitis | Phase 1 | Completed | Pfizer | 16 | 2025-10-03 | 2026-09-09 |
| DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial VKA, Direct Oral Anticoagulant (DOAC) - Atrial Fibrillation (AF), Stroke (in Patients With Atrial Fibrillation) | Early Phase 1 | Not yet recruiting | Population Health Research Institute | 100 | 2025-09-03 | 2025-06-08 |
| Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam Dabigatran, Rivaroxaban - Cerebral Venous Thrombosis | Recruiting | Hieu Trung Dinh | 69 | 2025-07-11 | 2026-10-09 | |
| Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation Apixaban, Aspirin - Stroke, Ischemic Stroke | Phase 4 | Recruiting | Assistance Publique - Hôpitaux de Paris | 1148 | 2025-06-18 | 2026-06-05 |
| Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers ALG-097558, Dabigatran, Itraconazole - COVID-19 | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 51 | 2025-05-13 | 2026-05-18 |
| Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. Aspirin, Clopidogrel, Ticagrelor - Thrombosis, Bleeding | Active not recruiting | Petrovsky National Research Centre of Surgery | 500 | 2025-05-01 | 2026-01-22 | |
| Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage Direct-Acting Oral Anticoagulants (used as per local standard practice) - Traumatic Intracranial Haemorrhage | Phase 3 | Recruiting | Walton Centre NHS Foundation Trust | 1084 | 2025-03-10 | 2026-06-18 |
| Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis Dabigatran, Enoxaparin - Portal Vein Thrombosis, Liver Cirrhosis | Phase 2 / Phase 3 | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 120 | 2025-01-31 | 2025-02-10 |
| A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body dabigatran etexilate, BI 1291583 - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 14 | 2025-01-23 | 2025-08-13 |
| Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions Dabigatran Etexilate Capsules 150 mg - Healthy Volunteer, Dabigatran | Phase 1 | Unknown | International Bio service | 60 | 2024-09-25 | 2024-06-06 |
| A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood Zongertinib, Dabigatran-etexilate, Rosuvastatin - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 32 | 2024-08-20 | 2026-01-09 |
| Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis Dabigatran Etexilate 150mg, Rivaroxaban 20 MG Oral Tablet - Cerebral Venous Sinus Thrombosis | Phase 3 | Recruiting | Kafrelsheikh University | 200 | 2024-08-09 | 2024-08-13 |
Showing 20 of 261. Sign in to see all of them.
Atrial Fibrillation (81) · Stroke (25) · Venous Thromboembolism (25) · Ischemic Stroke (14) · Hemorrhage (12) · Thrombosis (11) · Thromboembolism (10) · Pulmonary Embolism (7) · Venous Thrombosis (6) · Intracranial Thrombosis (5) · Neoplasms (5) · Atrial Flutter (4) · Coronary Disease (4) · Intracranial Hemorrhages (4) · Ischemic Attack, Transient (4)
Boehringer Ingelheim (79) · Bayer (13) · Pfizer (13) · Bristol-Myers Squibb (6) · Population Health Research Institute (4) · Brigham and Women's Hospital (3) · Canadian Network for Observational Drug Effect Studies, CNODES (3) · Peking University Third Hospital (3) · University of Alberta (3) · Assistance Publique - Hôpitaux de Paris (2) · AstraZeneca (2) · Centre Hospitalier Universitaire de Saint Etienne (2) · Deutsches Herzzentrum Muenchen (2) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2) · Herlev and Gentofte Hospital (2)
United States (59) · Germany (49) · Canada (38) · France (31) · Italy (26) · Spain (26) · Sweden (25) · Netherlands (24) · Denmark (23) · United Kingdom (23) · Belgium (21) · Austria (18) · Czechia (18) · Russia (18) · Norway (16)
Gunnar H Gislason, MD, PhD (2) · Julinda Mehilli, MD (2) · Madeleine Durand, MD, MSc, FRCPC (2) · Alexandru Chicos, MD (1) · Allan Skanes, MD, FRCPC (1) · Andre R Duraes, Professor (1) · Armin Schultz, MD (1) · Arvindh N Kanagasundram, MD (1)
PMID 24081972, PMID 27807306, PMID 18190818, PMID 22709460, PMID 22995531, PMID 23425163, PMID 23991661, PMID 24344086, PMID 26578849, PMID 28230262, PMID 31667735, PMID 34022170, PMID 36150047, PMID 36700520, PMID 38348778, PMID 10591382, PMID 11546885, PMID 12917889, PMID 17869635, PMID 18705914, PMID 18815396, PMID 19966341, PMID 20665856, PMID 20723861, PMID 21225098, PMID 22015331, PMID 22078863, PMID 22435369, PMID 23182947, PMID 23264523, PMID 23355673, PMID 23493340, PMID 24682348, PMID 24691436, PMID 24846496, PMID 25060026, PMID 25211369, PMID 25604089, PMID 25777666, PMID 26088268, PMID 26304866, PMID 26364029, PMID 26511221, PMID 26514352, PMID 26612979, PMID 26892845, PMID 26993976, PMID 27056964, PMID 27357738, PMID 27558002
2014 (4), 2017 (3), 2019 (3), 2004 (2), 2005 (2), 2018 (2), 2009 (1), 2015 (1), 2016 (1), 2023 (1), 2025 (1), R21AR065089 (1), R34HL113404 (1)